Ninety One (UK)’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,154,102
Closed -$80.1M 331
2017
Q1
$80.1M Sell
1,154,102
-24,587
-2% -$1.71M 0.4% 78
2016
Q4
$78.6M Sell
1,178,689
-49,364
-4% -$3.21M 0.41% 80
2016
Q3
$81.4M Sell
1,228,053
-8,604
-0.7% -$588K 0.4% 78
2016
Q2
$79.5M Buy
1,236,657
+16,193
+1% +$1.11M 0.41% 84
2016
Q1
$78.9M Buy
1,220,464
+144,650
+13% +$9.6M 0.43% 78
2015
Q4
$77.1M Buy
1,075,814
+124,428
+13% +$9.2M 0.44% 79
2015
Q3
$73.1M Sell
951,386
-208,698
-18% -$16.8M 0.46% 78
2015
Q2
$86M Buy
1,160,084
+146,093
+14% +$10.5M 0.49% 73
2015
Q1
$73.5M Sell
1,013,991
-664
-0.1% -$46.2K 0.43% 82
2014
Q4
$67.1M Sell
1,014,655
-69,153
-6% -$4.22M 0.41% 87
2014
Q3
$59.4M Buy
1,083,808
+14,655
+1% +$831K 0.35% 95
2014
Q2
$62.2M Buy
1,069,153
+581,465
+119% +$34.2M 0.36% 99
2014
Q1
$30.2M Buy
+487,688
New +$28.4M 0.2% 121

Other funds holding MD

Ninety One (UK)'s MD Position: Q2 2017 in Review

Ninety One (UK) sold out of Pediatrix Medical (MD) in Q2 2017, closing a stake of 1,154,102 shares — an estimated $80.1M sold.

Ninety One (UK) first reported a position in MD in Q1 2014 and held it in 13 quarters. The position peaked at $86M in Q2 2015. 332 funds tracked by Wall St. Rank hold MD as of Q2 2017.

  • Ninety One (UK) reported no remaining Pediatrix Medical position as of Q2 2017 after selling out during the quarter.
  • Ninety One (UK) sold 1,154,102 Pediatrix Medical shares in Q2 2017, an estimated $80.1M.
  • Ninety One (UK) first reported a position in Pediatrix Medical in Q1 2014 and held it in 13 quarters.
  • Ninety One (UK)'s Pediatrix Medical position peaked at $86M in Q2 2015.
  • 332 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2017.

Based on Ninety One (UK)'s 13F filing for Q2 2017, filed 11 Aug 2017.